Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Limited has informed BSE that its Board of Directors meeting is scheduled for 21st May 2026. The main agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March 2026, along with the Auditor's Report. The company has also disclosed that the trading window has been closed since 1st April 2026 for directors and designated persons, and will remain closed until 48 hours after the results are declared. This is a standard pre-results disclosure under SEBI listing regulations. No specific business proposals or financial details have been disclosed in this notice.
This is a routine board meeting notice confirming scheduled Q4 FY26 results approval. The actual impact on shareholders will only be visible when the financial results are released after the meeting. The closed trading window is standard practice ahead of earnings announcements.